US EditionCandela Launches Dual-Wavelength Laser for Vascular and Dermatologic Conditions
Summary by Plastic Surgery Practice
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Candela Launches Dual-Wavelength Laser for Vascular and Dermatologic Conditions
The platform, cleared for pediatric and adult use, combines a 595 nm pulsed dye laser with a 1064 nm Nd:YAG wavelength and features improved treatment speed, precision, and patient comfort. Candela Corp announced the launch of the Vbeam Pro platform for the treatment of vascular and dermatologic conditions at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery. The Vbeam Pro device, US Food and Drug Administration-cle…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
